Choosing Wisely Africa: Insights from the front lines of clinical care
- PMID: 35872184
- DOI: 10.1016/j.jcpo.2022.100348
Choosing Wisely Africa: Insights from the front lines of clinical care
Abstract
Background: A multidisciplinary Task Force of African oncologists and patient representatives published the Choosing Wisely Africa (CWA) recommendations in 2020. These top 10 recommendations identify low-value, unnecessary, or harmful practices that are frequently used in Sub-Saharan Africa (SSA). In this study, we describe agreement and concordance with the recommendations from front-line oncologists across SSA.
Methods: An electronic survey was distributed to members of the African Organization for Research & Training in Cancer (AORTIC) and oncology groups within SSA using a hierarchical snowball method; each primary contact distributed the survey through their personal networks. The survey captured information about awareness of the CWA list, agreement with recommendations, and concordance with clinical practice. Descriptive statistics were used to summarize study results.
Results: 52 individuals responded to the survey; 64% (33/52) were female and 58% (30/52) were clinical oncologists. Respondents represented 15 countries in SSA; 69% (36/52) practiced exclusively in the public system. Only 46% (24/52) were aware of the CWA list and 89% (46/52) agreed it would be helpful if the list was displayed in their clinic. There was generally a high agreement with the recommendations (range 84-98%); the highest agreement was related to staging/defining treatment intent (98%). The proportion of oncologists who implemented these recommendations in routine practice was somewhat lower (range 68-100%). Lowest rates of concordance related to: the use of shorter schedules of radiotherapy (67%); discussion of active surveillance forlow-risk prostate cancer (67%); only performing breast surgery for a mass that was proven to be malignant (70%); and seeking multidisciplinary input for curative intent treatment plans (73%).
Conclusion: While most frontline SSA oncologists agree with CWA recommendations, efforts are needed to disseminate the list. Agreement with the recommendations is high but there are gaps in implementation in routine practice. Further work is needed to understand the barriers and enablers of implementation.
Keywords: Africa; Choosing wisely; Harmful practices; Overuse; Value-based care.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Choosing Wisely Africa: Ten Low-Value or Harmful Practices That Should Be Avoided in Cancer Care.JCO Glob Oncol. 2020 Jul;6:1192-1199. doi: 10.1200/GO.20.00255. JCO Glob Oncol. 2020. PMID: 32735489 Free PMC article.
-
Are the Choosing Wisely Canada Cancer recommendations relevant and up to date with the current evidence?J Cancer Policy. 2023 Mar;35:100406. doi: 10.1016/j.jcpo.2023.100406. Epub 2023 Jan 21. J Cancer Policy. 2023. PMID: 36693524
-
Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care.J Oncol Pract. 2015 May;11(3):e296-303. doi: 10.1200/JOP.2015.004325. J Oncol Pract. 2015. PMID: 25980018
-
Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care.Lancet Oncol. 2019 Apr;20(4):e218-e223. doi: 10.1016/S1470-2045(19)30092-0. Epub 2019 Mar 8. Lancet Oncol. 2019. PMID: 30857957 Review.
-
The Choosing Wisely Oncology Canada Cancer List: An Update.J Cancer Policy. 2023 Sep;37:100431. doi: 10.1016/j.jcpo.2023.100431. Epub 2023 Jun 28. J Cancer Policy. 2023. PMID: 37391095 Review.
Cited by
-
Choosing Wisely-Barriers and Solutions to Implementation in Low and Middle-Income Countries.Curr Oncol. 2022 Jul 19;29(7):5091-5096. doi: 10.3390/curroncol29070403. Curr Oncol. 2022. PMID: 35877263 Free PMC article. Review.
-
The first Choosing Wisely Africa conference: a roadmap to value-based cancer care in Africa (16th December 2022, Senegal).Ecancermedicalscience. 2023 Mar 6;17:1517. doi: 10.3332/ecancer.2022.1517. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37113728 Free PMC article.
-
Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments.Curr Oncol. 2022 Aug 16;29(8):5774-5791. doi: 10.3390/curroncol29080455. Curr Oncol. 2022. PMID: 36005193 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials